PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -99.4% | 12,477 | -99.0% | 0.00% | -100.0% |
| Q2 2022 | $2,258,000 | -38.3% | 1,207,316 | -0.1% | 0.01% | -20.0% |
| Q1 2022 | $3,661,000 | -34.4% | 1,208,226 | -18.1% | 0.01% | -37.5% |
| Q4 2021 | $5,578,000 | +234.8% | 1,475,778 | +358.0% | 0.02% | +220.0% |
| Q3 2021 | $1,666,000 | +45.8% | 322,241 | +8.0% | 0.01% | +25.0% |
| Q2 2021 | $1,143,000 | -45.1% | 298,363 | -63.2% | 0.00% | -50.0% |
| Q1 2021 | $2,082,000 | +22.1% | 810,140 | +18.8% | 0.01% | +14.3% |
| Q4 2020 | $1,705,000 | +21.4% | 681,957 | +0.6% | 0.01% | -12.5% |
| Q3 2020 | $1,404,000 | -10.7% | 678,038 | +33.6% | 0.01% | -20.0% |
| Q2 2020 | $1,573,000 | +15.2% | 507,500 | +24.5% | 0.01% | -23.1% |
| Q1 2019 | $1,366,000 | -33.3% | 407,783 | -47.0% | 0.01% | -43.5% |
| Q4 2018 | $2,047,000 | +153.3% | 769,551 | +433.7% | 0.02% | +187.5% |
| Q3 2018 | $808,000 | -13.5% | 144,200 | -21.7% | 0.01% | -27.3% |
| Q2 2018 | $934,000 | – | 184,248 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |